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ABSTRACT 
 
Tuberculosis is one of the major public health problems in prisons worldwide. 
Environmental and host risk factors propagate the spread of tuberculosis in prisons.  
Among these risk factors are high HIV rates, overcrowding, poor nutrition and 
ventilation in prisons. 
In Malawi, case notification rates of smear positive tuberculosis of up to 442/100,000 
in prisons against 63/100,000 in the general population have been reported. 
A national tuberculosis policy for prisons was developed in 2007, which recommends 
screening of prisoners for TB upon entry to prisons, and also during incarceration of 
which only the latter has been started. 
Screening for tuberculosis during incarceration, is resource consuming. Since the 
commencement of screening in Malawi prisons, no assessment on its utility in 
detecting smear positive tuberculosis, and its (screening) effect on passive case 
notification rates of smear positive tuberculosis has been conducted. This study 
assessed the utility of screening from 2009 to 2010. 
 
This was a retrospective mixed descriptive and analytical study based on a 
quantitative approach. It was conducted in six prisons, which were grouped equally 
into maximum and medium security prisons. The study assessed the yield of smear 
positive TB cases diagnosed in three rounds of ACF in relation to extra (additional) 
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costs incurred. Additionally, it measured the effect of ACF on inter-rounds and final 
passive case notification rates (PCNR) of smear positive TB. Cough for one week 
was the only inclusion criteria during screening. The Pearson’s chi-square test was 
used to look for statistical significance in change of PCNR.  
 
During each round of active case finding, three times the number of smear positive 
TB cases diagnosed in medium security prisons were detected in maximum-security 
prisons for every additional MKW 100,000 spent during screening. However, the 
number of smear positive TB cases diagnosed was progressively reducing with each 
subsequent round of active case finding in both maximum and medium security 
prisons. 
After each round of ACF, the PCNR of smear positive TB was reducing in both 
prison types and statistical significance reduction was seen after the second round, 
and it was only in the maximum security prisons where the PCNR of smear positive 
tuberculosis still remained significantly lower (alpha 5%) after the third round than of 
equal duration before commencement of ACF. 
The study concludes that ACF is only cost effective in maximum-security prisons and 
only two rounds of ACF could suffice to significantly reduce the PCNR to levels 
below the pre-ACF commencement.  
 16 
 
The study recommends a repeat of the same study at a later time to ascertain whether 
the average number of cases at 6, diagnosed per MKW100, 000 in MASP would still 
be the same as in the second round of ACF, so that a decision to conduct only two 
rounds of ACF would be made, and thereafter to continue with a strengthen passive 
case finding and contact tracing for progressive reduction or maintenance of low 
rates, of smear positive TB in prisons. 
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1.0 INTRODUCTION 
Tuberculosis is an infectious bacterial disease caused by Mycobacterium tuberculosis 
(and occasionally by Mycobacterium bovis and Mycobacterium africanum).  These 
organisms are also known as tubercle bacilli, because they cause lesions called 
tubercles, or as acid-fast bacilli (AFB) (Crofton, Horne & Miller, 1999, p.7). 
The disease can affect most tissues and organs but especially the lungs. The most 
important source of infection is a patient with lung, or pulmonary TB (PTB), who is 
coughing. 
Each year, tuberculosis affects nine million people and kills almost two million 
people, primarily in low and middle-income countries (World Health Organization 
(WHO), 2009, p.32). Tuberculosis control is one of the key priorities in the sixth 
Millennium Development Goal (WHO, 2006, p.8). 
 
1.1 Transmission of tuberculosis 
 
Tuberculosis is transmitted from an infectious source to susceptible persons primarily 
through the air (Crofton et al., 1999, p.9). Infection with Mycobacterium tuberculosis 
can occur at any age. An individual’s risk of infection depends on the extent of 
exposure and his or her susceptibility to infection. The risk of infection in a 
susceptible individual is higher with close, prolonged, indoors exposures to a person 
with sputum smear positive PTB.  
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The risk of transmission of infection from a person with smear-negative PTB is low 
(20%), and even lower from someone with EPTB. “In non immune-compromised 
populations only about 5% of infected people develop the disease within a year and a 
further 5% develop the disease during their lifetime” (Nyirenda, 2006, p.147). 
 
Most infected persons do not experience clinical illness and are usually asymptomatic 
and noninfectious. However, infection can persist for years, and infected persons can 
remain at risk for developing clinical TB at anytime, especially if the immune system 
becomes impaired.  
 
The chance of developing disease is greatest shortly after infection and steadily 
lessens as time goes by (WHO, 2004, p.24). HIV infection has had a great impact in 
the  progression to active TB in cases of recent infection with tuberculosis than that 
caused by reactivation of tuberculosis in an HIV positive individual; this was shown 
in a study where clustering was more common in patients who were HIV positive 
(Glynn et al., 2005, p.486). A recent study in Nigeria showed that at least 24% of 
people with HIV infection developed TB within one year of imprisonment (Chigbu & 
Iroegbu, 2010, p.331). 
“Without treatment, by the end of 5 years 50% of PTB patients will be dead, 25% 
will be healthy (self cured by strong immune defense) and 25% will remain ill with 
chronic infectious TB” (WHO, 2004, pp.24-25). 
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The source of smear positive tuberculosis can be from new infections as well as 
reactivation of latent tuberculosis. Long-term studies in low-prevalence countries in 
Europe, the United States and Japan have used molecular strain typing to estimate the 
contribution of recent transmission on TB disease. Transmission rates of between 
34% and 60% were responsible for new active TB cases (Fox & Marks, 2010, p.3). 
In other studies, in high incidence populations, 58% of TB cases in South Africa 
(Verver et al., 2004, p.354), and more than 65% of smear positive TB cases in 
Malawi (Glynn et al., 2005, p.484) were attributed to recent infections. However, a 
study in South Africa suggests that there may be an underestimation of the true 
proportions. The common risk factors for transmission of TB in the two studies were: 
smear positive TB, duration of residence and HIV positivity .The HIV prevalence 
was 13% in the population understudy in Malawi and most of the contacts leading to 
infection may have just been casual.  
 
It is not clear which one of either transmission from new infections or reactivation 
leads to a considerable number of incident smear positive tuberculosis in prisons. A 
study within the prisons system in Catalonia, found that recent transmission of TB 
contributed substantially (51%) to the overall incidence of TB disease in Barcelona 
prisons. However, this finding was much lower than estimated in prison population of 
Madrid at 74% (March et al., 2000, p.532). “Nearly 50% of those inmates included in 
transmission chains, active transmission was documented to have occurred at a prison 
that was operating at 17% above designed holding capacity, and where a large 
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proportion of inmates are convicted to terms of more than 1 year. A further 39% of 
cases occurred at a prison that was characterized both by crowding with an 
occupancy rate of 167%,” (March et al., 2000, p.532) and an extremely mobile 
population, but most contacts leading to infection may just be casual.  
 
1.2 Diagnosis of tuberculosis 
 
Definitive diagnosis is through isolation of the organism causing the disease, 
Mycobacterium tuberculosis. This can be done through culture or nucleic acid 
amplification. However, these methods are beyond the reach of low and middle-
income countries. The DOTS strategy for diagnosis of tuberculosis recommends the 
use of microscopy smear through the Ziehl-Nelsen stain to find smear positive 
tuberculosis (WHO 2004, p.51).  
 
A patient with a positive culture for the Mycobacterium tuberculosis complex or with 
two-sputum smear positive for AFB (where culture is not routinely available) is 
considered a “definite” case. See Table 1.0 for classification TB (WHO, 2002, pp.12-
13). In addition, chest X-rays are used to diagnose smear negative tuberculosis, 
coupled with clinical signs. 
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Pulmonary Tuberculosis can be suspected if a patient presents with the following 
symptoms: 
 Persistent cough for three weeks or more 
 Fever 
 Chest pain 
 Shortness of breath 
 Loss of weight 
 Haemoptysis 
 
Extra-pulmonary Tuberculosis (EPTB) can present with the general symptoms 
described above; however patients may complain of the following symptoms, 
depending on the affected organ: 
 Swelling glands (TB Lymphadenitis) 
 Headache (TB meningitis) 
 Backache (TB spine) 
 Abdominal pain or distension (TB peritonitis) 
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TABLE 1.0: CLASSIFICATION OF TUBERCULOSIS 
 
Type Description 
Pulmonary Tuberculosis 
(PTB). 
Smear-positive PTB 
A patient with at least two sputum specimens positive 
for acid-fast bacilli on microscopy. 
 
Smear-negative PTB 
 A patient who has been coughing for > 3 weeks with at 
 least two sputum specimens negative for acid-fast 
bacilli on microscopy 
Extra-pulmonary 
tuberculosis. 
 
Pleural effusion 
Pericardial disease 
Lymphadenopathy 
Peritonitis and/or gastrointestinal disease 
Meningitis 
Spinal or bone disease  
Genito-urinary disease 
Skin disease 
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1.3 Identifying tuberculosis suspects 
TB suspects can be identified by different approaches. This can be done either 
actively or passively. However, active case finding requires more resources and the 
prevalence of TB in a particular community will determine which approach to use to 
diagnose a disease since screening for a disease is determined by the prevalence of 
the disease and resources availability. The WHO DOTS system recommends passive 
case finding of TB except in high-risk populations such as prisoners (WHO, 2006).  
 
1.4 Screening 
 
Screening is the presumptive identification of unrecognized disease by application of 
tests, examinations or other procedures, which can be applied rapidly. It seeks to 
identify positive or suspicious findings from apparently well people so that they are 
referred for diagnosis. Screening is provider initiated. Wilson and Jungner added, 
selective screening as screening of certain high-risk groups in the population through 
identification of symptoms and using tests (Holland, Stewart & Masseria, 2006, p.3). 
Screening also seeks to detect the disease earlier than it is advanced, and resulting 
into complications. Usually, screening is provided on a public health approach. In 
tuberculosis control, screening is referred to as active case finding.  
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1.4.1 Active case finding of smear positive tuberculosis 
 
Active case finding in tuberculosis disease entails searching for disease among people 
exposed to an infectious case. Active case finding can have two functions: - primary 
and secondary prevention.  
 
The rationale of active case finding as primary prevention, is that identifying and 
treating undiagnosed active tuberculosis cases earlier, will reduce further 
transmission of the tuberculosis infection to other population members (Etkind & 
Veen, 2000, as cited in Fox & Marks, 2010, p.3; Ward, Marciniuk, Pahwa & 
Hoeppner, 2004, p.595), hence cutting the transmission cycle. 
 
Cases that are identified earlier, would be put on treatment to avoid complications, 
which would take a lot of time to rehabilitate, hence this is secondary prevention. The 
current WHO approach to the management of tuberculosis, the DOTS, does not 
promote routine active case finding in low and middle-income countries (WHO, 
2006, p.12), except among high risk groups of HIV-infected individuals, prisoners 
and contact of smear positive TB. 
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Case detection and treatment success are core elements of TB control. If conducted 
promptly, effectively, and systematically, these elements could lead to the reversal of 
a growing TB incidence and to the reduction of TB prevalence (Song, Castillo-
Chavez & Aparicio, 2002, as cited in Fox & Marks, 2010, p.3) and mortality. 
However, the reduction in tuberculosis prevalence might be slow (Fox & Marks, 
2010, p3). 
 
Consequently, DOTS, the Stop TB Strategy, and the Global Plan to Stop TB 2006–15 
are all oriented toward the two fundamentals of case detection and treatment. In terms 
of case detection, DOTS traditionally relies on the passive detection of cases or 
passive case finding. Case finding methods should be directed towards identifying 
infectious TB patients if the TB epidemic is to be controlled. 
 
Active case finding results in the diagnosis of additional undetected tuberculosis 
cases among chronic coughers. In Uganda, 33(18%) smear positive TB cases were 
diagnosed following an active case finding in a slum setting (Sekandi, Neuhauser, 
Smyth & Whalen, 2009, p.508); in Ethiopia, two different active case finding found 
similar results as in Uganda. Over 90% among the 23 cases (Demissie, Zenebere, 
Berhane & Lindtjorn, 2002, p.581) and 38(80/100,000) (Yimer, Holm-Hansen, 
Yimaldu & Bjune, 2009, p.1399) additional smear positive cases were diagnosed. In 
India, an active search for suspects for smear positive TB among community 
members, detected twice the number of cases (26 versus 13) diagnosed passively in 
 26 
health centers in the same catchment area over one year (Aneja, Chandrasekhar, 
Seetha, Shunmuganandan & Samuel, 1984, pp. 72-73). The researchers concluded 
that active case finding could supplement DOTS to yield additional smear positive 
TB cases. 
 
 Active case finding, leads to early diagnosis and thus shortens the duration of 
infectiousness and prevents transmission to other members of the community 
(Verver, Bwire & Borgdoff, 2001, p.424; Sekandi et al., 2009, p.508; Yimer et al., 
2009, p.1399; Boon et al., 2008, p.1348). As delays have been observed in passive 
case finding in prisons, ACF would avoid this.  
 
Smear positive cases diagnosed through ACF, are less symptomatic or asymptomatic 
and infectious (Monney & Zellweger, 2005, p.469; Ward et al., 2004, p.594; Boon et 
al., 2008, p.1348) or have shorter duration of symptoms (Verver et al., 2001, p.419). 
Due to this fact, they are more likely to be missed on a smear microscopy. However, 
these cases are more likely to refuse or default from treatment (Cassels, Heineman & 
Le Clerq, 1982, p.175; Santha et al., 2003, p.262; Boon et al., 2008, p.1348), but 
proper supervision on intake of drugs, can result into the same treatment outcome as 
those passively detected  (Monney & Zellwenger, 2005, p.472) or even better as the 
disease is not advanced. 
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Since a long time ago, different screening methods have been employed in active case 
finding. These are symptom screening, chest x-ray, tuberculin skin testing (TST) and 
Interferon gamma-release essay. Most of these apart from symptom screening have 
proved to be expensive (Golub, Mohan, Comstock & Chaisson, 2005, p.1199), and 
the selection of diagnostic methods and combination of passive and active case 
finding, including frequency of active case finding, largely depend on the prevalence 
of TB, HIV or both, in the community or prison setting and on availability of 
resources. Symptom screening and smear microscopy are the recommended methods 
in middle and low-income countries. However, TB symptom screening alone may be 
insufficient in some cases, as it may fail to detect some pulmonary cases (Sanchez et 
al., 2009, p.1250). 
 
There are three case finding strategies that can be implemented in prisons. These are: 
Passive case finding (self referral) being implemented under DOTS, screening on 
entry to prisons and active case finding in the imprisoned (incarcerated) population. 
“Using one strategy in isolation is unlikely to effectively detect TB cases in prisons” 
(WHO, 2001, p.103). 
 
Screening during entry is aimed at preventing prisoners from bringing the TB into 
prisons as many may come from background of high prevalence of TB (WHO, 2001, 
p.104). This has been evident where 2.7 %( 46/1696) of prisoners entering prison in 
Brazil have been diagnosed with TB (Sanchez et al, 2009, p.1249). 
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Active case finding during incarceration, identifies prevalent TB cases from the 
existing reservoir among the incarcerated population thereby reducing the prevalence 
of active TB, through removal of the bulk of infectious cases following diagnosis and 
prompt treatment (WHO, 2001, p.104). Transmission is likely to be reduced, hence 
also reducing incidence of TB. However, with time, the prevalence begins to increase 
especially with HIV positive TB cases as they have a shorter duration to progress to 
active TB (Dodd, White & Corbett, 2011, p.1&4). Active case finding is difficult to 
continuously sustain in resource poor settings. Due to this, interrupted rounds are 
recommended hence called periodic active case finding. 
 
Alternation of active case finding with passive case finding (PCF), can result into 
increased or fewer cumulative (total) cases diagnosed if the passive case finding is 
very strong (Dodd et al., 2011, p.6), however there is a tendency that total cases 
initially increase. The magnitude of total cases diagnosed is usually determined by 
the initial burden of TB, duration between each round of ACF and efficiency of each 
round. Dodd et al. (2011, p.5) suggested in the model “that the higher the initial case 
detection rate, the more likely that fewer total cases of TB would be diagnosed under 
the intervention period and vice versa.” Dodd et al. (2011, pp. 6-7), further suggested 
that reductions in cumulative HIV infected TB caseload are more likely where more 
than 40% of TB incidence is due to recent infection than HIV uninfected people. 
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1.5 Passive case finding of tuberculosis 
This is one of the components of DOTS as a means of case detection. It entails 
examining people who have a cough for 2 or 3 weeks (chronic cough), and 
spontaneously visit health facilities due to respiratory symptoms. Chronic cough had 
both high sensitivity and positive predictive value in the pre-HIV era for diagnosis of 
active TB and led to the DOTS strategy (Corbett et al, 2010, p.1251). 
 
Passive case finding (PCF) relies on complete accessibility of TB diagnostic services 
and high health seeking behaviour of people. However, there is a risk of delays in 
seeking health. These delays might be from the health provider or the TB suspects’ 
perspective. In places like prisons, corrupt practices and lack of health services may 
limit the ability of the prisoner to seek care (WHO, 2001, pp. 41-42) hence affecting 
passive case finding resulting into transmission of TB to other prisoners. 
 
In prisons, passive case finding seeks to identify incident cases which develop into 
TB after entry to prisons and those missed through other case finding strategies such 
as entry screening (WHO, 2001, p.105). 
 
Despite the fact that cases diagnosed through passive case finding are usually at 
advanced stage of disease and may have poor treatment outcome, PCF is less 
expensive and simpler for programs to implement. 
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1.6 Contact tracing (Investigation) of TB 
Following up and investigation of contacts of index TB cases (smear positive TB 
cases) is one of the vital control measures for TB spread. It has led to detection of 
active TB in 1% of all contacts, and 10% of TB cases have been diagnosed due to 
contact tracing (Underwood, White, Baker, Law & Moore- Gillion, 2003, p.59). 
Contact tracing relies on prompt notification of the disease (Tuberculosis). A study 
done by Neely et al. (2009, p.50), following an outbreak of TB among IPT users in 
London, showed that contact tracing should be done in both household and casual 
contacts of smear positive TB and close contacts of smear negative TB. Most of the 
rates in prisons are similar to those in outbreak situations. So the above 
recommendations on contact tracing can be followed. The priority and urgency of 
conducting contact tracing should be guided by the risk of transmission, which is 
perceived to be so high in prisons due to overcrowding and poor ventilation. Since 
contact tracing is part of screening and the cases diagnosed through this approach are 
usually asymptomatic, extra efforts are to be made so that these cases complete their 
treatment and they are cured. 
 
Active case finding in prisons can be done during entry into prison, mass screening 
during incarceration and through contact investigation, while self-referral is passive 
case finding. Usually active case finding in prisons is done as a supplement to passive 
case finding (Golub et al., 2005, p.1198). 
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1.7 Sputum microscopy 
Diagnosis of Tuberculosis rests mainly on the identification of the tubercle bacilli 
either by sputum smear microscopy or by culture.  
Two or three sputum smears need to be collected for each tuberculosis suspect. 
Patients with negative smears need further investigation (mentioned below) and 
should never be told that there is nothing wrong with them before such investigations 
are done. 
 
Sputum collection should be done in open air or in a ventilated room, away from 
other people, to avoid infecting them. 
 
Sputum specimens should be sent to the laboratory as soon as possible to ensure 
examination is done within one week of collection and stored in a refrigerator or in a 
cool, safe and dark place. 
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1.8 TB treatment outcome for smear positive pulmonary TB patient 
 
There are six treatment outcomes for smear positive TB. These are: - 
 
1. CURED: patient who is sputum smear negative in the last month of treatment 
and on at least one previous occasion. 
 
2. TREATMENT COMPLETED: patient who has completed treatment but 
who does not meet the criteria to be classified as cured or failure. 
 
3. TREATMENT FAILURE: patient who is sputum smear positive at five 
months or later during treatment. 
 
4. DIED: patient who dies for any reason during the course of treatment. 
 
5. DEFAULTER: patient whose treatment was interrupted for 2 consecutive 
months or more. 
 
6. TRANSFER OUT: patient who has been transferred to another recording and 
reporting unit and for whom the treatment outcome is not known (WHO 
2002, p.13). 
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TREATMENT SUCCESS: sum of patients cured and those who completed 
treatment. 
 
1.9 Burden of tuberculosis in prisons 
Tuberculosis is becoming concentrated among the high risk and difficult to reach 
populations. Among this population are prisoners. Each year, over 9 million people 
are incarcerated in prisons worldwide as either remand or sentenced prisoners 
(Walmsley, (n.d), p.1). 
 
Higher rates of TB have been reported in prisons both in Africa (O’Grady et al., 
2011, p.174) and in developed countries than in the general population. However, 
these rates are worse in developing countries than developed countries (Table1.1) 
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TABLE 1.1: SHOWING BURDEN OF TB IN PRISONS IN DIFFERENT  
                      COUNTRIES 
COUNTRY RATE per 
100000 
MEASURE SOURCE 
Ivory Coast 5800 Incidence of smear 
positive TB 
Koffi et al, 1997 
Brazil 2700 Prevalence of 
smear positive TB 
Sanchez et al., 2005 
Russia 2369 to 869 over 
2 years 
Incidence of TB  Lobacheva, 2005 
Spain (Barcelona)  2766 to 174 over 
13 years 
Smear positive 
incidence rate 
Rodrigo et al., 2002 
Thailand 354.8 Prevalence rate of 
smear positive TB 
Jittimanee et al., 
2007 
Botswana 3797 Point Prevalence of 
TB 
CDC, 2003 
Zambia 4005 Prevalence rate of 
culture positive TB 
Habeenzu et al., 
2007 
Cameroon 3517 Prevalence rate of 
TB 
Noeske, 2006 
Pakistan 3900 Prevalence of TB Shah et al., 2003 
Turkey 341 Mean point 
prevalence 
Kiter et al., 2003 
Taiwan 208 Prevalence of TB Chiang et al., 2002 
Thailand 568 Prevalence of 
smear positive TB 
Sretrirutchai, 2002 
Georgia 5995 Prevalence of 
smear or culture 
positive TB 
Aerts et al., 2000 
France 215 Incidence of TB Hanau-Bercot, 2000 
USA 113 Prevalence of TB Bock, Reeves, 
Marre& Voe, 1998 
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1.10 Risk factors for TB transmission and propagation in prisons 
 
“Although close or household contacts have a greater individual risk of infection than 
the general population, this is not necessarily due to household exposure alone Other 
shared risk factors may also confer a higher risk of acquiring infection,”as argued by 
Aparicio, Capurro and Castillo- Chavez (2000, as cited in Fox & Marks, 2010, p.3). 
As most prisoners come from poor and minority groups with lower education levels 
(Rodrigo et al., 2002, p.1091), it is not surprising to see that prisons have higher rates 
of tuberculosis than the general population. The risk factors for transmission and 
propagation of tuberculosis in prisons are categorized into environmental and host 
factors (Table 1.2). 
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TABLE 1.2: Risk factors for transmission and propagation of active TB within  
                       prisons      
ENVIROMENTAL RISK FACTORS HOST RISK FACTORS 
Poor ventilation in prison cells and 
congregate settings within the prisons 
Poor nutrition and micronutrient 
deficiencies 
Close contact between prisoners due to 
restricted prison compounds 
Stress and anxiety 
Close contact between prisoners and 
prison staff 
Immune-suppression example HIV 
infection 
Overcrowded sleeping quarters (many 
prisoners per cell) 
 
Smoking and chronic obstructive airway 
disease 
Close contacts between prisoners and 
visitors 
Addictive drugs 
Poor prison health services Lack of sunshine and vitamin D 
deficiency. 
 
Source: O’Grady J et al., 2011, p.175 
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From the table 1.2, it is seen that other risk factors apart from contact contribute to 
spread of tuberculosis. “The relative contribution of domestic exposure to an 
individual’s overall risk of acquiring disease will also depend upon disease 
prevalence in the population under study. Unsurprisingly, contact screening studies 
show that rates of active disease are higher among contacts of tuberculosis patients in 
high-prevalence countries” (Rieder, 2003, as cited in Fox and Marks, 2010, p.4). 
 
1.11 Cost Effectiveness analysis 
 
Cost effectiveness analysis (CEA) measures the effects against the resource inputs of 
two different approaches of implementing a program, which aims at one goal, hence 
assist in decision-making. When applied in health, it identifies areas (locations) or 
interventions of a health program that are efficient and also help in improving the 
program. 
 
Results in cost effectiveness analysis can be expressed as cost per unit effect or effect 
per unit of cost, and the latter is important when the program is working within a 
budget constraint (Drummond, O’Brien, Stoddart & Torrace, 1997, p. 13). “ CEA 
may also compare two actions in health whose effects are not measured directly but 
may achieve other clinical objectives that can be clearly linked to improvements in 
patients outcome, for example treatment outcome of TB patients between actively 
and passively detected cases (Drummond et al., 1997, p. 13). 
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1.12 The research problem, scope and significance of the study 
 
In Malawi, just like in other Sub-Saharan African countries, tuberculosis (TB) 
remains a huge public health problem.  TB is one of the biggest causes of adult 
morbidity and mortality, whose greatest impact is on the poor, from backgrounds of 
overcrowding, poor nutrition and inadequate hygiene and sanitation. Since 1985, 
Malawi has experienced an almost six fold increase in TB case notification rates. 
Death rate has also been proportionally high. The escalating TB notification rate and 
the high death rate are largely attributed to the HIV epidemic, which fuels the TB 
situation (Malawi National TB Program, 2011, p.2). 
 
Tuberculosis is one of the major public health problems in Malawi prisons. It is the 
highest cause of death from a single disease alone in Malawi prisons (Graph 1.0). 
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Graph 1.0: Causes of death in Malawi prisons in the year 2009 
 
 
Source: Annual Report of Malawi prisons, 2009 
 
 
 
In a prevalence study of pulmonary TB conducted in Zomba central prison, a rate of 
5,142/100,000 (Nyangulu et al., 1997, p.1286) was registered, compared with 
209/100,000 in the general population in 1996 and the prevalence of smear positive 
TB was at 2% (Nyangulu et al., 1997, as cited in Banda, Gausi, Harries & Salaniponi, 
2009, p.1558).  
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As the study by Nyangulu et al. (1997), only focused on one large prison, another one 
was done but with special focus on smear positive TB using sputum microscopy. This 
time around, 18 out 22 prisons were studied. The study found a period prevalence of 
smear positive TB of 0.7% (54/7661) but main urban prisons of Zomba, Maula and 
Chichiri had a higher period prevalence at 1.1% versus 0.3% in district prisons 
(Banda et al., 2009, p.1558). Though the prevalence of smear positive TB in Zomba 
prison reduced from 2.0% in 1996 to 1.5% in 2005, the study found that the reduction 
was not statistically significant. 
 
Through the years, the prevalence rate in prisons has decreased though still high as 
compared to that of the general population. This is being reflected through reduction 
in case notification rates. In a countrywide surveillance of tuberculosis of 2008 by 
Kanyerere et al. (2012, p.12), tuberculosis case notification rate in prison was 
835/100,000 as compared to general population at 219/100,000.The case notification 
rate of smear positive tuberculosis was 442/100,000 compared to 63/100,000 in the 
general population. Smear positive cases contributed to 53% of all TB cases in the 
year 2007 while smear negative and Extra-pulmonary TB contributed to 29% and 
18% respectively. The highest numbers of TB cases were recorded in central (urban) 
prisons of Zomba, Maula and Chichiri (Table 1.4). Most of the inmates who 
contributed to smear positive tuberculosis were convicts. 
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Table 1.3: Malawi Prison Tuberculosis Case Load in 2007 
 
Name of 
Prison 
Smear 
Positive 
Smear Negative EPTB Total Grand 
Total 
M F M F M F M F 
Mwanza 6 0 1 0 4 0 11 0 11 
Chitipa 0 0 0 0 0 0   0 0 0 
Mulanje 3 0 6 0 8 0 17 0 17 
Makande 0 0 0 0 0 0 0 0 0 
Bvumbwe 0 0 0 0 0 0 0 0 0 
Thyolo 0 0 0 0 1 0 1 0 1 
Chichiri 33 0 13 0 5 0 51 0 51 
Nsanje 2 0 4 0 0 0 6 0 6 
Chikwawa 3 0 6 0 2 0 11 0 11 
Ntchisi 0 0 0 0 0 0 0 0 0 
Nkhotakota 2 0 1 0 2 0 5 0 5 
Kasungu 4 0 0 0 2 0 6 0 6 
Mzimba 7 0 1 0 1 0 9 0 9 
Karonga 2 0 0 0 0 0 2 0 2 
Mzuzu 1 0 0 0 0 0 1 0 1 
Nkhatabay 0 0 0 0 0 0 0 0 0 
Bzyanzi 0 0 0 0 0 0 0 0 0 
Ntcheu 6 0 1 0 1 0 8 0 8 
Mangochi 1 0 0 0 0 0 1 0 1 
Mikuyu 2 0 0 0 0 0 0 0 0 0 
Domasi 0 0 0 0 0 0 0 0 0 
Mikuyu1 0 0 0 0 0 0 0 0 0 
Mpyupyu 0 0 0 0 0 0 0 0 0 
Kachere 0 0 0 0 0 0 0 0 0 
Dedza 4 0 0 0 0 0 4 0 4 
Zomba 45 0 23 0 18 0 86 0 86 
Maula 27 1 25 0 5 1 57 2 59 
 
Source: Malawi Prisons Annual report, 2008 
 
 
 
 42 
Recognizing the high rates of TB in Malawi prisons, and existence of most risk 
factors (Table 1.1) for transmission and propagation of active TB in prisons, the 
National Tuberculosis Control Program (NTP) and Prison Medical Services 
established collaboration on control of tuberculosis in prisons in 1996. Among other 
things, the collaboration centers on referral of TB cases/suspects from prisons to 
Ministry of health facilities, supervision of prison medical staff by NTP staff, 
provision of free microscopes to the prisons, provision of free anti-TB drugs and 
laboratory supplies to the prisons and biannual TB review workshops with prison 
medical staff. 
As   one   way of showing commitment to control of tuberculosis in Malawi prisons, 
the Ministry of Health together with the Ministry of Home Affairs and Internal 
security and other relevant stakeholders developed a policy document for tuberculosis 
control in Malawi prisons. This policy is a guiding tool for control of tuberculosis in 
Malawi prisons. 
Early case finding is one of the activities integral to prevention of tuberculosis 
transmission as it expedites the treatment of tuberculosis. Integration of active and 
passive case finding with the priority to detect infectious cases is recommended for 
case finding in prisons (WHO, 2001, p.103). Periodic active screening of prisoners 
during incarceration and screening upon admission to prisons by asking for 
respiratory symptoms are some of the approaches to fast track the control of 
tuberculosis stipulated in the policy (Malawi Ministry of Health, 2007a, p.6).  
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However, a short communication by Harries et al. (2004, p.615), shows that during 
on entry active case finding of TB during the period 1999- 2002, from the available 
data on admission screening and smear positive PTB, 423 prisoners were diagnosed 
with smear positive PTB. Of these, 34 (8%) were identified through admission 
screening and 389 (92%) while already within the prison system. However, the 
duration of stay before diagnosis of TB was made is not available. 
Nyangulu et al. (1997), also found that in all prisoners except one, symptoms of TB 
had developed after entering prisons and suggested that there was a possible active 
transmission of tuberculosis within prisons, an observation that was also done by 
other studies in a prison (Stead, 1978, p.2545; Bellin, Fletcher & Safyer, 1993, 
p.2228; Martin et al., 1994, p.929; Centers for Disease Control and Prevention 
(CDC), 1992; Jones, Craig, Valway, Woodley & Schaffner, 1999, p.557; Chaucer, 
1955, p.684). 
The Malawi prisons formally started implementing periodic active screening in 6 
prisons in July 2009. The recommendation is to conduct periodic active screening 
biannually (Malawi Ministry of Health, 2007a, p.7). However, the activity has been 
done on eight monthly intervals due to logistical issues. Malawi just like most 
countries has not fully started implementing active case finding during admission to 
prisons due to logistical problems ranging from human resources to financial 
constraints. Implementation of active case finding during admission has to be 
considered carefully as little yield (34/423) was seen from the data of 1999-2002 as 
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reported by Harries et al. (2004, p.615). No official results are available for periodic 
screening during incarceration in Malawi prisons. 
After considering cost and prevalence in different regions of the world, using models 
of three approaches of ACF, Murray and Salomon (1998, p.S14) concluded ACF 
strategies combined with DOTS would yield enormous benefits in areas with high TB 
prevalence and millions of cases and death could be averted. However, this would 
also depend on the diagnostic and screening method. 
Periodic active case finding is aimed at removing a backlog of smear positive cases 
and a few incident cases that subsequently arise and missed by passive case finding. 
Studies in Malawi, Cameroon and Botswana showed that over half of prisoners with 
active sputum TB had been missed by routine diagnostic services and could 
potentially be transmitting TB. 
 
Delays have been observed in passive case finding in prisons. In a prevalence study 
of TB in Malawi prisons, the median duration of cough before diagnosis was 4 weeks 
(2-52) (Nyangulu et al., 1997), and over 50% of TB suspects in prison were screened 
after 4 weeks of TB symptoms (cough) and 42% were screened within 2 to 4 weeks 
of onset of symptoms (Kanyerere et al., 2012). Hence, implementation of active case 
finding would avoid these gaps and delays in diagnosis and treatment initiation in 
prisons, an observation also made by Dara, Grzemska, Kimerling, Reyes & Zagorskiy 
(2009) and Kiter et al. (2003), who recommended that active case finding be 
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continued in prisons, as a supplement to passive case finding. In the context where 
there is very high prevalence of TB and HIV in prisons, more aggressive approach is 
required to detect smear positive TB and cure it.   
 
However, active case finding has cost implications in the sense that, more resources 
are needed to perform ACF. The study will assist the Malawi prison in facilitating 
planning, management and efficient allocation of resources among prisons for active 
case finding to improve the cost effectiveness use of resources by identifying prisons 
or prison characteristic where periodic active case finding be of most value as the 
main purpose of active case finding is to identify more cases. 
 
1.13 Research   questions 
 
1. How much improvement in TB diagnosis can be attributed to an added   
program of Active Case Finding for TB? 
2. What is the added cost for implementing the associated Active Case Finding    
activity? 
3. How many smear positive TB cases were diagnosed for the added costs 
during each session of active case finding in prisons? 
4. What was the trend of passive case notification rates of smear positive TB 
following each round of active case finding (ACF) during the period under 
study? 
5.  Should active case finding be equally implemented in all prisons in Malawi? 
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1.14 Research objectives 
1.14.1 Main Research objective 
 
To determine the magnitude of smear positive TB cases detected for added cost 
during periodic active case finding, and its (active case finding) effect on the passive 
case notification rate (TB case rates) of smear positive TB in Malawi prisons. 
 
1.14.2 Specific research objectives are to: - 
 
1. Establish the absolute number of cases diagnosed during sessions of periodic 
active case finding in Malawi prisons from 2009 to 2010. 
2. Identify the added costs spent on periodic active case finding in Malawi 
prisons from 2009 to 2010. 
3. Calculate the number of smear positive TB cases diagnosed for added costs 
during periodic active case finding in Malawi prisons from 2009 to 2010. 
4 Determine the passive case notification rates of smear positive tuberculosis 
after each round of active case finding. 
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1.15 Hypotheses 
The extra costs of implementing three rounds of active case finding in prisons justify 
the added utility of the program by reducing passive case notification rates of smear 
positive TB. 
I. H0 (Null Hypothesis): The extra costs of implementing three rounds of active       
case finding in prisons do not justify the added utility of the program as there 
was no reduction in passive case notification rates of smear positive TB. 
 
II. H1 (Alternative Research Hypothesis): The extra costs of implementing three 
rounds of active case finding in prisons justify the added utility of the 
program by reducing the passive case notification rates of smear positive TB. 
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2.0 TUBERCULOSIS CONTROL AND PREVENTION IN MALAWI 
PRISONS 
 
    2.1 Tuberculosis control in Malawi 
The Malawi National Tuberculosis Program (MNTP) has the whole responsibility to 
manage tuberculosis control activities in Malawi. A program manager who reports to 
the directorate of preventive health services (DPHS) heads it. 
 
The directorate of preventive health services has the mandate of setting national 
standards for primary health care, which includes disease surveillance, immunization 
program, health promotion, inspection and environmental aspects related to health. It 
is also responsible for disease control, epidemiology and emergency/ epidemic 
preparedness. Lastly, the DPHS as a hub of prevention has the task of ensuring that 
there is multi-sectoral collaboration at national level among all health stakeholders in 
preventive medicine. 
 
The MNTP has been implemented as a vertical program since 1964, until in 2005 
when it started realigning its planning, approach and budgeting to be in line with the 
Malawi Joint Health Sector Wide Approach (SWAP).  
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The main responsibility of the MNTP is to ensure that the national standards in TB 
control in the country are adhered to through evidence based information and quality 
control. Collaboration of activities has been between national TB officers and district 
level until lately, following decentralized health policy structure where zonal TB 
offices have been established. The role of zonal TB officers is supervising and 
strengthening the district health management teams in terms of planning, 
implementation, diagnostic, quality control, monitoring and evaluation of all TB 
control activities in the district (Appendix 1).  
 
Malawi is divided into 5 zones on health administration. Each zone has one zonal TB 
officer who is responsible for 4 to 6 districts and reports directly to the national TB 
office. The district health management team (DHMT), under the overall of the 
District Health Officer is responsible for resource mobilization, coordination of 
activities and operational research in TB control within the district. The DHMT 
appoints a district TB officer, who may either be a clinician/nurse or an 
environmental health personnel whose duties are to coordinate all the TB control 
activities at individual patient, community and district level on behalf of the DHMT.  
 
The district TB officer supervises all the health cadres that are involved in the 
management of TB at both community and facility levels. These include clinicians, 
nurses, laboratory technicians, community health nurses, environmental health 
officers and health surveillance assistants (HAS). However, HAS are more involved 
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in community level surveillance (passive case finding) of TB, health education and 
promotion as well as follow up of both TB suspects and patients. Community 
members form community and health facility committees, which do also volunteer in 
TB activities. 
 
An analysis of TB case finding statistics over the past 25 years shows that there was a 
five-fold increase in new TB case notifications between 1984 and 2000. There was 
also an increase in TB/HIV co-infected patients, reaching a maximum of 77% in 2000 
(Malawi Ministry of health, 2000, p.42), which has now decreased to 63% in the 
2010 cohort (WHO, 2011, p.62). Death rate has also been proportionally high.  
 
Since 1984, Malawi has responded to the TB epidemic by adopting the World Health 
Organisation (WHO) advocated DOTS strategy which is based on five key elements:  
1. Political commitment with increased and sustained financing 
2. Case detection through passive case detection with quality-assured 
bacteriology. 
3. Standardized short course chemotherapy with supervision and 
patient support. 
4. An effective drug supply and management system. 
5. Monitoring and evaluation system and impact measurement (WHO, 
2006, p.4).  
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Delivery of this strategy in Malawi is through integration of tuberculosis control 
within the existing health services.  To date, favourable treatment outcomes are being 
reported save for the high death rate currently at 15% (Malawi NTP, 2011a, p.3). 
 
The Malawi National Tuberculosis Control Program is well established in delivery of 
TB services such that it has gained a very good reputation in Sub-Saharan African 
(SSA) region. The program has attempted to be responsive to the needs of different 
social groups through the development of community-based activities to intensify 
case finding among the poor (Simwaka et al., 2007).  
 
However, there are a number of challenges that the program is experiencing. These 
challenges are: increase in number of TB cases due to HIV co-infection, under 
diagnosis of TB cases due to passive case finding strategy, persistent poverty and 
malnutrition, gender inequity, lack of human resources and emergence of MDR-TB. 
Although the country is yet to register an extensive drug-resistant TB (XDR-TB) 
case, however, 1320 cases of MDR-TB cases have since been reported, with 871 new 
cases in 2010 and 449 being on retreatment (WHO, 2011, p.141). 
 
The Malawi Government started implementing a three-year plan of joint TB and 
HIV/AIDS services consistent with WHO/UNAIDS recommendations in 2002, with 
the aim of reversing the burden of TB. Following the declaration of TB as an 
emergency in Africa by African Ministers of health in October 2005, the Malawi 
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Government was the second country in Africa to declare TB an emergency in the year 
2007 (Malawi NTP, 2011a, p.4), and the National TB Control program came up with 
a 5 year development plan for 2007-2011. 
 
The main objectives of the plan were to promote early health seeking behaviour of 
TB suspects through advocacy, communication and social mobilization (ACSM), 
equitably improve and maintain case finding and good diagnostic practices, 
strengthen NTP capacity to monitor and support the delivery of effective TB 
treatment, including TB/HIV control, increase and maintain collaboration with health 
training institutions and the private sector, conduct sustained relevant operational 
research in TB control, and improve and maintain human resources capacity at all 
levels to effectively manage, monitor and evaluate the NTP( Malawi Ministry of 
Health, 2007b, p.6). 
 
2.2 Burden of Tuberculosis in Malawi 
According to World Health Organization’s Global TB report of 2011, there was an 
estimated incidence of 33000 cases (all forms) of TB in Malawi at the rate of 219 
cases per 100000 populations. However, case notification in the year 2010 has been 
well more than the estimated case detection rate of 65%, with 22536 cases notified 
(WHO, 2011, p.124). The TB case notifications then stabilized between 2001 and 
2005, before showing a 1% decline in the past 4 years (Malawi NTP, 2011a, 
p.7)(Graph 2.0). 
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Graph 2.0: Trend of case notification and incident rate in Malawi over the last 
20 years from 1990 
 
Source: WHO 2011 
 
 
Prisons contribute less than 1% of the total notified cases towards national figures as 
seen following a surveillance of tuberculosis in Malawi prisons in 2008 and only 2% 
towards smear positive TB cases in 2006 and 2007(Malawi NTP, 2011b), despite 
having very high rates than the general population. The country program has made 
progressive tremendous improvement in treatment success rate over the years (Graph 
2.1) and achieving an 88% treatment success rate for smear positive cases in 
2009.Following improvements in treatment success rates, there been a resultant 
reduction in mortality rate (Graph 2.2).  
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Graph 2.1: Treatment success rate of TB in Malawi from 1995 to 2009 
 
 
Source: WHO 2001 
 
 
 
 
Graph 2.2: Trend of mortality rate due to TB in Malawi from 1990 to 2010 
 
 
Source: WHO 2011 
 
The National TB Control program plans to do a prevalence survey towards end of 
year 2012(Malawi NTP, 2011, p.5). Once this is done, correct figures of incidence 
will be determined as the current ones are just estimates by W.H.O. 
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2.3 Tuberculosis and HIV/AIDS Co- infection 
The introduction of Antiretroviral (ART) treatment in 2004 in Malawi may also have 
played a significant role in reducing the case notifications in Malawi. Up to end of 
June 2011, there were 287089 people who were alive and on ART (Malawi Ministry 
of Health, 2011, p.3) out of the estimated 1 million infected people (Prevalence of 
HIV at 12%).  
 
ART patients undergo routine TB screening at every visit so that undetected TB 
could be diagnosed, as it is believed to be responsible for a good proportion of early 
deaths. Out of the current population alive on ART, 261251(91%) were screened for 
TB and 356 were TB suspects while 1889(1%) were confirmed as current TB patients 
of which 1569(83%) were already on TB treatment and 320 were yet to start (Malawi 
Ministry of Health, 2011, p.3). In 2010, 46% of TB patients in Malawi were started 
on ART (WHO, 2011, p.62). 
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2.4 Other Interventions for Tuberculosis control in Malawi 
Other interventions implemented by the NTP in the control of TB are: Vaccination of 
infants with BCG immediately after birth, disseminating information, educating the 
communities and communication (IEC) to improve the community’s health seeking 
behavior. BCG vaccination whose national coverage is at 97% is aimed at preventing 
children from TB and also severe forms of TB, example TB Meningitis. In the year 
2010, only 153 cases of TB were notified in the population less than 15 years old.  
 
BCG vaccination falls under the prevention and treatment of vaccine preventable 
diseases in the Malawi Essential health care package (EHP), while IEC is part of the 
support activities in the POW to achieve the EHP (Malawi Ministry of Health, 2004, 
p.20). 
 
Apart from BCG vaccination and IEC, the NTP also promotes better clinical practice 
with isoniazid preventive therapy (IPT) for people living with HIV (PLWHA) and 
children who are household contacts of index smear positive pulmonary TB cases, 
cotrimoxazole prophylaxis to reduce morbidity/mortality among HIV- infected TB 
patients, safe TB case management within the healthcare facilities to prevent 
transmission to healthcare workers and active TB case finding among high risk 
groups, PLWHA and prisoners inclusive. However, the screening of TB among 
prisoners is not through chest X-rays and isonoazid preventive therapy is not 
routinely offered to prisoners. 
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2.5 Treatment of Tuberculosis in Malawi 
The Malawi government changed the treatment of TB to fixed drug combination in the year 
2007. Several drugs are combined into one to three tablets. 
 
2.5.1 Anti-tuberculosis drugs used in Malawi 
New TB patients are treated with first line anti-tuberculosis drugs. This comprise a 
combination of rifampicin, isoniazid, pyrazinamide and ethambutol tablet, 
abbreviated as RHZE in the first 2 months, followed by 4 months treatment with a 
combination of rifampicin and isoniazid (RH). Relapse TB cases are treated with 
second line anti-tuberculosis drugs RHZE for the first 3 months followed by a 5 
months continuation phase of RHE. Therefore, it should be noted that the duration of 
treatment are 6 and 8 months for new PTB and relapse cases respectively (Malawi 
Ministry of Health, 2012, pp.39-41). 
 
2.5.2 Side effects of anti-tuberculosis drugs 
Anti-tuberculosis drugs have side effects. These side effects are grouped into major 
and minor. Some side effects are common while others are rare. Every drug has its 
own side effects despite being in fixed combination. Other side effects like peripheral 
neuropathy (PNP) are preventable.  
Peripheral neuropathy is due to use of isoniazid (INH) and is very common in HIV 
positive TB patients and in alcoholics (WHO, 2004, p.129). Apart from peripheral 
neuropathy, joint pains are one of the common side effects that are observed in 
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patients who are on TB treatment, which also needs medication treatment. An 
incidence of 2% of peripheral neuropathy has been reported in one study (Mandel, 
1959, p.293). Deficiency of vitamin B complex, more specifically pyridoxine has 
been suggested as the cause of peripheral neuropathy. However, other studies have 
suggested that isoniazid has inhibitory effect on pyridoxine (Mandel, 1959). In 
situations where malnutrition is endemic like in prisons, possibility of a higher 
incidence of peripheral neuropathy in patients on isoniazid should be expected. The 
incidence of PNP also increases up to 30 to 40 %( Mandel, 1959, p.293) with 
increased amount of INH above the normal amount of 300mg.Most other common 
side effects require discontinuation of the drug responsible for side effects and 
introduce the drugs later in small doses after the side effect has resolved. 
Prevention of peripheral neuropathy requires daily intake of pyridoxine 10mg through 
out the use of INH. If a patient develops peripheral neuropathy, 75 mg daily of 
pyridoxine is used. Usually, peripheral neuropathy is common in the first 2 months of 
TB treatment. 
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2.6 MALAWI PRISONS SERVICE 
 
The Malawi Prisons Service (MPS) is a government department constitutionally 
mandated under Chapter XVII of the Republican Constitution, and, operates within 
the statutory parameters of Chapter 9:02 of the Laws of Malawi to keep and 
rehabilitate offenders under lawful, humane custody. 
 
2.6.1 Establishment of Malawi prisons 
 
The MPS is divided into 4 regions administratively. These are northern, central, 
eastern and southern regions (Figure 2.0). 
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Figure 2.0: Map of Malawi showing regions and districts that prisons in the study 
are located 
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The MPS has currently 32 prison stations that are distributed in all the regions (Appendix 
2). The southern region has more prisons (34%) while there is equal number of prisons in 
the other regions, each contributing 22% (Graph 2.3).  
Graph 2.3: PIE CHART SHOWING DISTRIBUTION OF PRISONS BY REGION   
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The stations are categorized into maximum, medium and low security prisons, based on 
security risk prisoners in the respective prisons pose. The prisons have different section 
for the safe keeping of females and young offenders. Malawi prisons, has 4 prisons which 
are regarded as maximum-security prisons. These are Zomba, Chichiri in Blantyre, Maula 
in Lilongwe and Mzuzu in the Northern region. These prisons, house prisoners with long 
sentences and also those remanded on serious offences such as homicide, armed robbery 
and others. However, Zomba prison is the only one that house prisoners on life or death 
sentences. 
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Medium and low security prisons are usually found in districts. Some of these are prison 
farms where different crops are grown. Among the medium security prisons are 
Chikwawa, Ntcheu and Mzimba district prisons. These district prisons have farms. 
Prisoners, whose sentences are not beyond 4 years, are in principal housed in medium or 
low security prisons. If their sentences are more than 4 years, prisoners are sent to 
maximum-security prisons. However, this is not always the practice (Chirwa, 2001, p.5), 
as isolated cases were found where they are not supposed to be. 
 
2.6.2 Prison population in Malawi 
 
Currently, the Malawi prisons house between 11500 and 12500 prisoners on the daily 
basis (Malawi Prisons Service, 2009). The prison population has been increasing over the 
years. In the year 1997, it was 5557, rose to 7728 in the year 2000 and in June 2001, it 
was 7800(Chirwa, 2001, p.6). 
All the prisons in Malawi are faced with the problem of congestion. The total holding 
capacity for Malawi prisons is 5610 prisoners but as of December 2009, the prison had 
11511prisoners. This represented a 205% occupancy rate. (Graph 2.4) 
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Graph 2.4: TOTAL HOLDING CAPACITY VERSUS EXCESS BODIES IN 
MALAWI PRISONS AS OF 31 DECEMBER 2009. 
 
Source: Malawi prison report, 2009 
 
 
 
 
The situation of overcrowding is worse in the maximum-security prisons of Zomba, 
Chichiri, Maula and Mzuzu where occupancy rate is more than 250% (Table 2.0). 
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Table 2.0: Malawi prisons holding capacity and occupancy rate 
Prison Station Prison 
population 
Number of 
cells 
Holding 
Capacity 
Occupancy 
Rate (%) 
Chitipa 120 3 60 200 
Karonga 122 5 80 153 
Mzuzu 439 3 90 488 
Nkhatabay 142 5 80 178 
Mzimba 527 8 400 132 
Byanzi 36 1 30 120 
Dedza 278 4 120 232 
Kachere 73 9 54 135 
Kasungu 320 8 240 133 
Maula 1759 12 480 366 
Ntchisi 111 2 60 185 
Nkhotakota 334 3 120 278 
Ntcheu 256 2 80 320 
Mangochi 120 5 90 133 
Domasi 318 8 240 133 
Mikuyu 1 385 10 240 160 
Mikuyu 2 166 7 210 79 
Mpyupyu 204 10 200 102 
Zomba central 2294 108 756 303 
Chichiri 1513 19 570 265 
Bvumbwe 189 3 90 210 
Chikwawa 477 8 240 199 
Makande 182 1 360 51 
Mulanje 412 8 240 172 
Mwanza 311 4 160 194 
Thyolo 102 3 90 113 
Makhanga 61 1 30 203 
Nsanje 150 6 120 125 
Rumphi 110 2 80 138 
Total 11511 268 5610 205 
 
Source: Malawi prisons Services annual report, 2009 
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In 2001, Zomba,Maula and Mzimba prisons were densely populated with a prisoner 
having 1 square meter of space for accommodation. The situation was worse in Chichiri 
and Mzuzu prisons (Chirwa, 2001, p.9), where a prisoner had on average of 0.5 and 0.8 
square meters of space respectively. As at this time, the prison population was only 7800. 
This situation is expected to have worsened as the prison population has increased to 
11511 in the year 2009. 
There has been a steady decrease in offenders remanded to prisons over the past 4 years 
(Malawi Prisons Service, 2009, p.24). In 2009, there were around 1400 offenders 
awaiting trial while those convicted were around 9700. This implies that more offenders 
are still slapped with custodial sentences. Offenders remanded to prisons, are segregated 
from convicted prisoners as practically as possible. However, this is not to the maximum 
due to lack of space.  
Female prisoners are the least group, among the prisoners category (Graph 2.5). They 
constitute less than 2% of the prison population in Malawi; hence they are less congested 
in their section. 
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Graph 2.5: Categories of inmates within prisoners’ population in Malawi 
 
Source: Malawi prisons report, 2009 
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2.7 Structural description of prisons where the periodic active case finding 
was implemented 
These prisons were in two categories of maximum and medium security prisons. 
2.7.1 Maximum security prisons 
 
1. Zomba central prison 
It was built in 1939 in the colonial period. It has 6 sections. These are first offender, 
female, aged over 65, block A and B, and condemned criminals’ sections. It is built out of 
burnt bricks and has a tall perimeter brick fence (Figure 2.1a). There are a total of 108 
cells (Table 2.0) of different dimensions, with habitable area of 1814.4 square meters 
(m). 
Most cells have 2 to 4 windows that are high up, and each window measures 0.5m by 
0.5m or less than that (Figure 2.1b). Cells in the condemned criminal section have 1 
window each but are usually occupied by one prisoner. There is usually mixing up of 
prisoners during day time, on an open ground (Chirwa, 2001, p.8) and there is no 
available shade such that most prisoners spent their time under shade within cells. 
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Figure 2.1a: Part of the perimeter brick wall fence measuring 12 meters around 
Zomba central prison  
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Figure 2.1b: Depicting one of the cells at Zomba central prison with small windows 
close to the roof 
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2. Chichiri prison 
 
This prison is in Blantyre city, southern region of Malawi, and was built in the 
postcolonial era. It has both female and male sections. The male section has remand 
and convicted sections. Like Zomba central prison, Chichiri has a high (10 meters) 
perimeter brick wall fence around the prison. The whole prison has a total of 19 cells. 
Unlike in Zomba, these cells are bigger though a total surface area is 948.5 square 
metres. On average, each cell has 3 or 4 windows of 1.5 m by 1.2m. Usually, prisoner 
on the male section mix up and some spend their time within cells, during daytime, as 
there is no proper shade to protect them from sunlight. The sleeping within the cells is 
on the floor (Figure 2.2). 
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Figure 2.2: Inside a sleeping cell at Chichiri prison 
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3. Maula prison 
Maula prison is in Lilongwe city, central region. Initially was built to be a remand 
prison only, but due to lack of space in other prison, it started admitting convicts as 
well. This was built in the 1960s. The prison does not have a perimeter brick wall 
fence. It has several fences of barbed wire around it (Figure 2.3a). The prison has 12 
cells with a total area of 1069 square meters.  Each cell has 4 windows of 1.5m by 
1.2m and another 4 measuring 1 m by 0.5m on the front and back respectively (Figure 
2.3b). The prison has a very vast ground where prisoners spent time during day. It has 
female and male sections. Remand prisoners and convicts sleep in different cells. 
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Figure 2.3a: Perimeter fence around Maula prison 
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Figure 2.3b: Showing outside of a prison cell at Maula prison 
 
 
 
. 
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2.7.2 Medium security prisons  
 
1. Chikwawa prison 
This prison is in the southern region. Most features are similar to Zomba central 
prison in the sense that it has a perimeter brick wall fence and has cells with 4 
windows on both front and back of cells, measuring 1m by 0.5m, but very close to 
the roof such that ventilation is compromised. There are 8 cells with a total area of 
480 square meters. As a medium security prison, it has a farm where prisoners 
usually go out to farm. 
 
2. Ntcheu and Mzimba prisons 
Both Mzimba and Ntcheu prisons have more recent structures. They both have a 
perimeter brick wall fence around the prison. The new Mzimba prison was 
opened in the year 2007 while for Ntcheu, there has just been replacement of old 
tiny structures. 
 
Both prisons have farms where prisoners work during day. Each cell has 4 to 6 
well ventilated windows, measuring 1.5m by 1.2 m. Mzimba prison has 8 cells 
with a total area of 912 square metres while Ntcheu has only 2 cells with 226 
square metres. 
Mzimba has both male and female sections. Like Chikwawa, both Mzimba and 
Ntcheu as district prison have some remand prisoners who await court trial in 
their respective districts. 
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Figure 2.4: Aerial view of the modern Mzimba prison 
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2.8 Tuberculosis case finding in Malawi prisons 
Tuberculosis control takes place in all the prisons of Malawi.  The Malawi prisons 
adopted the DOTS system of management of tuberculosis cases. Prisoners do self-referral 
to the clinic or report to head of cell that report them to authorities within prisons. 
Prisoners with cough for 1 week are asked to submit 3 sputum specimens, which undergo 
direct microscopy. Sputum specimens collected at the prison are examined at the prison 
itself (if the prison has microscopy facilities) or are sent to the nearest health facility by 
the prison staff (if the prison does not have microscopy facilities). 
Below is a practical pathway for the diagnosis of TB cases in Malawi prisons (Figure 2), 
however this is not usually followed during passive case finding. 
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FIGURE 2.5 
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The decision to screen all prisoners with cough for 1 week or more follows local research 
by Banda et al, 2009 where by 10% of patients with short duration of cough 1 week or 
more had smear positive TB. This decision was also vindicated by Harries et al where 
164(39%) of 423 prisoners who were diagnosed with smear positive TB between 1999 
and 2002 had cough for 1 to 3 weeks.  
Screening of new prisoners is not routinely done in prisons, as was the case in the years 
1999 to 2002.Even in those prisons where it is done; the screening is not performed 
routinely due to some operational problems. 
In prisons with no medical staff, the general warden does the screening otherwise the 
prison medical staff does the screening.  
Prisoners suspected of having active TB are registered in the chronic cough register at the 
prison. Prisons with medical staff are provided with TB patient registers (equivalent to 
the district TB register) and TB treatment cards into which details of the TB patients are 
entered.  
Prisoners diagnosed with smear-positive PTB at the prison are registered and treated in 
the prisons according to national guidelines; including HIV treatment and care services 
(Malawi Ministry of Health, 2012). For prisons with no medical staff, prisoners 
diagnosed with smear-positive PTB used to be referred and treated at the nearest prison 
with medical staff. But this system stopped since 2008 as every prison now has a warden 
designated as a medical staff. Prisoners with chronic cough and negative smears or with 
symptoms and signs suggestive of extra pulmonary TB (EPTB) are referred to the nearest 
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district hospital for further investigations according to national guidelines (Malawi 
Ministry of Health, 2012)  
All patients diagnosed at each prison are also registered in their respective district 
hospital’s TB registry in order for the district TB coordinator to keep track of these 
patients. 
In a surveillance of tuberculosis in Malawi prisons done in 2008 by NTP, it was found 
that the prisons had 5 microscopists and these were in the 3 central prisons of Zomba, 
Maula and Chichiri, and also at Mzimba district prison  
The highest numbers of TB cases were recorded in central prisons such as Zomba, 
Chichiri and Maula. The surveillance also observed that the presence of prison medical 
staff is a determinant of TB identification in Malawi prisons  
Tuberculosis microscopists, underwent a 3 weeks TB microscopy training in 2007 and 
thereafter, the NTP supplied microscopes and all necessary supplies for these 
microscopist to start their work. 
The NTP and Central reference laboratory does quarterly quality control supervision of 
prisons TB microscopy centers. This is done by blindly checking the slides that were 
already prepared and read by microscopist and then the results are cross-matched. 
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2.9 Treatment of Tuberculosis in prisons 
Prisoners diagnosed with all form of TB, are treated according to national guidelines. 
Prisoners are admitted at the nearest hospital during the first 16 days of TB treatment 
unless have very severe major side effects, and thereafter return to prison for continuation 
of treatment under supervision of prison medical personnel.  
When an inmate is still on TB treatment at the time of his discharge, the prison medical 
personnel notifies the district TB officer who follows the inmate to the center where the 
inmate is referred to continue with treatment. The treatment outcome of TB treatment is 
sent to the specific prison where the prisoner was initiated on treatment. However, there 
have been cases where prisoners are lost due to provision of fake addresses or identities 
while in prison. A study done in Georgia also showed that prisoners on TB treatment 
were also missed following their release from prisons (Bock et al., 1998, p.361).  In 
Malawi, this is expected to end or minimize when the country fully implement national 
identity cards (Malawi Ministry of Health, 2007a, p.9). 
According to the regulations of Malawi prisons, no prisoner is supposed to keep drugs of 
any kind in a cell, hence all drugs including those of TB, are kept by prison personnel and 
a prisoner is asked to report daily to come for medication and take drugs before the prison 
personnel thereby ensuring that DOTS is followed. If the prisoner does not report for 
medication, it is the responsibility of the prison personnel to follow up to the cell of the 
prisoner and make sure that medication is taken as recommended. 
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2.10 HIV/AIDS situation in prisons 
Human immunodeficiency virus (HIV) is one of the risk factors for the progression of TB 
infection into active TB.HIV also increases the susceptibility of an individual to TB. The 
majority of published studies have found higher HIV prevalence in prison inmates. 
 
In west Africa, where HIV prevalence is less than 5% in the general population, prisoners 
were found to have markedly higher HIV prevalence in Ghana (19.2%)(Adjei et al., 
2008, p.34), Cameroon (10.4% to 25% depending on whether they had TB)(Noeske, 
Kuaban, Amougou, Piubello & Pouillot, 2006, p.27) and Nigeria (18%)(Adoga et al., 
2009, p.541). 
 
In Southern Africa, where HIV prevalence is greater than 10% in the general population, 
the prevalence was found markedly higher in Malawi (36.6%) (Chimphambano, 
Komolafe & Muula, 2007, p.226) though the sample size was small, Zambia 
(27%)(Simooya et al., 2001, p.1742) and South Africa (43.5%)(Goyer &Gow, 2001, 
p.130). The only exception was a Mozambican study conducted in 1990-91, which found 
a very low HIV prevalence in prison, at 0.6% (Vaz, Gloyd, Folgasa & Kreiss, 1995, 
p.42). 
 
Most of these studies were done in Central/urban prisons, where incarcerated prisoners 
have more serious offences and the prevalence may not be generalized to all the prisons 
within the countries. However, this still reflects that the general problem of HIV is high 
in prisons, as there are transfers of prisoners within prisons.  
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In Malawi, a study found an HIV prevalence of 74% in both TB and non-tuberculosis 
diagnosed prisoners in Zomba central prison in the year 1996(Nyangulu et al., 1997, 
p.1286), however this was not a systematically done research. Out of 278 TB patients in 
the year 2007, 269(97%) patients underwent HIV testing and counseling and 176(65%) 
of the total TB patients were HIV positive (Kanyerere et al., 2012, p.11). Lower rates of 
HIV infection in TB patients were observed in prisons of Ivory Coast at 30% (Koffi et al., 
1997, p.250) and Tanzania at 25.9% (Rutta, Mutasingwa, Ngallaba & Mwansasu, 2001, 
p.704).  
 
Following a prevalence survey of HIV, TB and Sexually-Transmitted infections in 
Malawi prisons done in 2011, the HIV rates were 41%, 23% and 19% in central, mid size 
and small size prisons respectively, with and average of 27% (Malawi Prisons services, 
2011, p.21). This HIV prevalence was more than 50% higher than in the adult general 
population (15-49 years), which stand at 12 %(Malawi Ministry of Health, 2007c). 
 
The evidence coming out shows that most sub Saharan Africa prisons are faced with the 
problem of overcrowding. Besides facilitating TB transmission, the close sleeping 
arrangement in prison cells and inadequate blankets result in prisoners sharing blankets, 
thereby increasing the risk of engaging in consensual and coercive sex (Jolofani & 
DeGabriele, 1999). This facilitates the transmission of sexually transmitted infection 
including HIV, with very high risk especially for the receptive partner. Cases of rape or 
sodomy have also been reported in prisons (Goyer & Gow, 2001; Jolofani & DeGabriele, 
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1999), which are likely to result in anal mucosa trauma that further increases the risk of 
HIV acquisition by the victim. 
 
The risk of sodomy in sub Saharan African prisons is made worse due to lack of basic 
commodities like food, soap, blankets and other supplies hence prisoners who have no 
external support from friends and relatives are particularly vulnerable to sexual abuse by 
fellow prisoners in exchange for food and other basic necessities. 
 
Homosexual practices have been reported in the majority of African studies in prisons. In 
Ghana, 30.8% and 22.7% of male and female prisoners reported homosexuality, 
respectively (Adjei et al., 2008, p.39), while in Nigeria, less than 10.7% male prisoners 
reported engaging in this practice (Adoga et al., 2009, p.541). 
 
In Southern Africa, a lower proportion of prisoners reported engaging in homosexuality; 
3.8% (Simooya et al., 2001, p.1742) and 8.4% (Simooya, Phiri, Sanjobo & Sichilima, 
1995, p.1388), in Zambia; 5.5% in Mozambique (Vaz et al., 1995, p.42) and 2.1% in 
Malawi (Chimphambano et al., 2005). However, a recent study done in 2011 in Malawi 
prisons, has reported that 9.8% and 4.1% of prisoners in maximum and medium security 
prisons respectively, are involved in homosexuality (Malawi Prisons services, 2011, 
p.28). 
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It is highly likely that homosexuality was grossly under-reported due to the illegality of 
the practice in these countries and severe punishment that prisoners undergo if found to 
be engaged in homosexual practices. It is apparent that the majority of prisoners engaging 
in homosexual practices does not have homosexual orientation before incarceration but 
simply engage in the practice due to prison environment (Jolofani & DeGabriele, 
1999;Goyer & Gow, 2001). 
 
Factors associated with homosexual practices include long stay in prison, use of alcohol 
and illicit drugs, the need for protection against bullying or for food and basic necessities 
(Simooya et al., 1995; Malawi prisons services, 2011). In Malawi, three more studies 
apart from the recently conducted in 2011, have reported the existence of homosexual 
practices and sodomy (Chimphambano et al., 2005; Jolofani & DeGabriele, 
1999;Zachariah et al., 2002, p.617). One of these studies inferred the existence of this 
practice based on the findings of new sexually transmitted infections and ruptured peri-
anal abscesses in male prisoners only (Zachariah et al., 2002, p.617). 
 
However, most prisoners are already at risk of HIV due to their background and lifestyle, 
and might get into prisons already infected as a study in Mozambique showed that 
inmates had very high frequency of sexual partners’ change and high reported history of 
sexually transmitted infection and low (9%) reported use of condoms (Vaz et al., 1995, 
p.42). 
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3.0 METHODOLOGY 
 
3.1 Research type and design 
This was a retrospective mixed descriptive and analytical study based on quantitative 
approach. The study evaluated data and additional costs during a period of about 1.5 
years, from June 2009 to December 2010, when periodic active case finding of smear 
positive TB were implemented (three rounds). 
 
Screening (ACF) was implemented every 8 months in the selected prisons. Each round of 
active case finding was done in 4 days. Afterwards, all TB suspects were reverting back 
to the routine passive case finding as stipulated by DOTS. 
 
Comparisons on passive case notification rates (PCNR) of smear positive TB during 
inter-active case finding rounds were compared. Passive case notification rates of smear 
positive TB for 8 months before June 2009 and after December 2010 were also 
calculated. These were also compared with inter-active case finding rounds rates 
(PCNR). An equal duration was deliberately chosen. 
 
The inclusion criteria for prisoners into the study were cough for one week or more. 
Prisoners who were already known TB patients were excluded from the study. 
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3.2 Study site and population 
The study was conducted in six of thirty-one prisons in Malawi. These six prisons 
composed of three maximum prisons, which are: Chichiri prison in Blantyre, Zomba 
central prison in Zomba and Maula prison in Lilongwe. The other three prisons were 
medium security prisons in the following districts: Ntcheu, Chikwawa and Mzimba. 
 
The six prisons keep about six tenth (6/10) of the whole prison population. Usually, the 
prison population fluctuate around 11500 prisoners. Each of the three maximum-security 
prisons has a daily prison population of between 1500 and 2100 prisoners and there is not 
much difference in the prisoners turn over each year. 
Data was reviewed regardless of a prisoner being a convict or on remand. 
 
3.3 Study period 
Data collection was undertaken from February to September 2011. Thereafter, a 
validation was done in March 2012.In the initial data collection period, the researcher 
was fully involved on the ground with two assistants who were briefed on what was to be 
collected. Thereafter, the assistants continued with feeding the researcher with data. 
 
 
 
 
 
 
 88 
3.4 Sources of data 
The Malawi prison maintained a manual information management system until the year 
2011 when some stations started acquiring computers and are changing to a computerized 
system. 
 
There is easy access to high quality demographic, admission history, place of 
accommodation and health records including tuberculosis data records despite the system 
being manual. However, difficulties are encountered if a prisoner is discharged from 
prison, as it may be hard to retrieve a file from old records. 
 
All prisoners are issued with a unique number and have files that facilitate access to their 
individual information on admission dates, case committed and duration of 
imprisonment. Health records and drugs for each patient are kept in the clinic or 
improvised room at prison as clinic. 
 
Other sources included vouchers from accounts department, where costs for fuel and 
allowances for staff doing the ACF were accessed. 
The following were the records that were reviewed in the prison information   
management system: 
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3.4.1 Prisons admission register 
Demographic record of prisoners is stored in this book. The date of birth, duration of the 
sentence and date of committal to prisons, area of origin and tribe are all recorded here 
against the prison number accorded to each prisoner. 
 
3.4.2 Medical information system 
There is a special register available at the registry of every prison which records 
information on sickness of prisoners who have been taken to the hospital for treatment if 
a prison does not have a clinic. 
 
The member of staff who is assigned to look at the health of all prisoners updates this, 
upon return from hospital. The diagnosis and treatment are recorded in this book. 
 
If the prison has a clinic, as is the case with the 4 maximum prisons, all patient records 
are entered in registers at the clinic. 
3.4.2.1 Documentation in TB control in Malawi prisons 
It is very important to have good record keeping and reporting system in Tuberculosis 
control. The following records are kept in prison.  
 
(a) Chronic Cough Register  
This is kept at every prison where information on a TB suspect is recorded and those 
given sputum containers are also indicated. When a chronic cough register is properly 
used, it helps the prison to assess their case detection.  
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(b) Tuberculosis Treatment Card  
This is kept in all prisons giving treatment or keeping drugs for a prisoner. When 
treatment has been completed, the card should be returned to the district hospital and 
retained by the DTO in his office.  
 
(c) District Tuberculosis Register  
This is maintained at all treatment centres. It is a requirement to register all TB patients 
started on treatment. These include new cases, relapses, failures, and treatment after 
default, and recurrent cases. All prisons that have health personnel have this register. The 
good thing is that every prison has at least one health worker since August 2008 
  
(d) Tuberculosis Outpatient Identity Card  
As drugs are collected from a district hospital for each prisoner patient, the prison health 
personnel keep this as a TB personal identification card for each prisoner. Health workers 
at the hospital use this card to identify TB patients and assist them appropriately, e.g. 
supplying drugs and collecting follow up sputum specimens. Health workers fill in the 
date of next appointment in the appropriate column. 
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(e) Request Form for Sputum-Smear Examination 
This form is filled whenever a patient has submitted specimens for sputum examination. 
Health workers write patients particulars, district TB registration number (for follow-up 
cases) and reason for examination in the appropriate spaces. This form is kept in all 
health units. 
 
(g)  Quarterly Report on Case Finding  
This form is used for reporting all TB cases registered at each prison in each cohort. 
Prisons health personnel fill it and sent to the district TB officers (DTO) for aggregation, 
record keeping and analysis who in turn send this information to the zone TB officer. 
 
(h) Tuberculosis Referral/Transfer Form  
This form is filled when transferring patients from prison to another treatment centre 
upon discharge from prison or within the prisons. Four copies of this form should be 
filled. One to be kept by the prison in a special file, the other to be taken by the patient to 
where the patient is referred, one to be mailed to where the patient is referred, and the 
fourth one is mailed to the DTO where the patient is going. Prison health personnel 
follow up all transfer out patients to ensure that they continue receiving their treatment. 
This form is kept at all prisons. 
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3.5 Data collection 
3.5.1 Data collection process 
Data collection was done through review of the above records. These records were 
accessed from the information management systems records in prison. The accounts 
section of Malawi prisons provided information from vouchers on finances spent on 
allowances for staff and fuel to travel them to respective prisons to conduct the active 
case finding.   
3.5.2 Type of data collected 
The following data was collected: 
a) The number of prisoners’ population at risk during each of the one and half year 
periods.  
b) The number of prisoners whose sputum was tested 
c) The number of prisoners diagnosed as Smear positive pulmonary TB 
d) The extra finances spent on active screening which includes staff allowances and 
fuel costs in each prison. 
3.5.3 Ethical considerations 
No formal request was made to the Malawi National Health Sciences Committee 
(MNHSC) as the work only involved looking at data that was already recorded during 
normal operations of TB control in prisons. 
However, permission was sought from the Malawi prison authorities to use the data and 
also have access on financial records spent during periodic active case finding 
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3.6 Research data analysis 
 3.6.1 Research paradigm 
The research paradigm in this study assumes that there will be a lot of benefits by 
implementing periodic active case finding of TB as supplement to DOTS (Golub et al., 
2005; Murray & Salomon, 1998)(See figure 3).  
 
It is believed that the prevalence of smear positive TB is high in Malawi prisons but case 
detection still low to moderate, together with a moderate completion rate. 
 
The assumption is that through active case finding, smear positive cases will be 
diagnosed earlier and prevent transmission to other prisoners considering the prevailing 
conditions, which favour the spread of TB in prison. 
 
It is assumed following transmission reduction; there will be reduction in both suspects 
and cases. After years of implementing ACF and controlling transmission, resources will 
be saved after preventing future cases with resultant reduction in treatment and 
rehabilitation costs (Golub et al., 2005), hence cost savings incurred. 
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3.6.2 Outcome variables (Units of data analysis) 
a) Smear positive TB case diagnosed for added costs during active case finding 
b) Passive case notification rate (TB case rates) of smear positive TB. 
 
3.6.2.1 Smear positive cases diagnosed for added costs during active case finding 
In this study, the main focus is to diagnose more cases so that they are put on treatment to 
reduce or stop transmission to other prisoners. Since the budget is a constraint, the results 
will be expressed as smear positive TB cases diagnosed for added costs. This will be 
expressed as cases diagnosed for every Malawi Kwacha (MWK) 100000 spent. 1 US 
dollar is equal to about 150 Malawi Kwacha. This will be done for every round of active 
case finding and also overall during the intervention for both maximum and medium 
security prison types 
 
3.6.2.2Passive case notification rate of smear positive TB 
In the course of reducing transmission of TB, a clinical objective of reducing TB case 
rates will is achieved. This will result in cost saving, as less microscopy of sputum will be 
done following reduction of suspects, and also saving on treatment. An intermediate 
measure of TB rates is passive case notification rates (PCNR).  
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3.6.3   Data Validity 
To improve data validity, the researcher intends to revisit the data mainly on duration of 
incarceration. However, where there were inconsistencies on the data, the researcher was 
verifying with the health worker at the source of data through telephone. 
The research data was also entered on the computer to track down if there was repetition 
of capturing same subjects more than once. The researcher did these entries into the 
computer.   
 
3.6.4 Data analysis tools 
Case notification rate of smear positive cases was calculated using formula provide in the 
Manual of program managers for TB (Appendix 3).  
 
Odds ratio (OR) was calculated to compare the change in case notification rate of smear 
positive TB before and after implementation of a round of active case finding. 
The Pearson’s Chi-square was calculated for each OR. The graphs were drawn using 
Microsoft Excel 2007 software. 
The total added costs for implementing periodic active case finding were calculated for 
each prison using the frequency of rounds of screening. During this intervention, 3 
rounds of active case finding were done. 
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3.6.5 Limitations of the research study 
The study could not determine the person years of prisoners as the records are mostly 
manual. If person years were established, it would have been possible to calculate the 
incidence of smear positive TB within the study period. The use of cough for one week as 
the only inclusion criteria might have also led to missing of some cases. 
 
3.6.6 Pearson’s Chi-squared tests and testing the hypothesis 
Since the data being analysed in the study is categorical, looking at cases diagnosed out 
of the exposed population, the Pearson’s chi-squared test was used in testing differences 
in consecutive passive case notification rates. Statistical significance was tested at alpha 
of 5%. 
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FIGURE 3.0 
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4.0 RESULTS 
A total of 35673 and 8419 prisoners went through the maximum and medium security 
prisons respectively over a period of two and half years under study. This population was 
predominantly males (99.5%). There was very high turnover of prisoners during the 
period. 
 
4.1 Contribution of ACF towards total smear positive TB cases diagnosed 
during the period of supplementing PCF with ACF 
 
Following three rounds of active case finding, fifty-five (55) cases out of 2614 suspects 
were diagnosed with smear positive TB in maximum security prisons while 10 cases out 
of 607 suspects were diagnosed from medium security prisons. This implies that to 
diagnose 1 case of smear positive TB in maximum-security prisons, 48 suspects had to 
have their sputum examined as opposed to 60 in the medium security prison. However, 
there was no statistical significant difference in the number of suspects who had their 
sputum examined to diagnose 1 case of smear positive TB between maximum and 
medium security prisons (chi-squared = 0.520; p< 0.50). 
 
From graph 4.0, it is seen that the number of smear positive TB cases reduce with each 
subsequent round of active case finding in both the maximum and medium security 
prisons, but the number of suspects was higher in the second round of ACF than in the 
first and third rounds more markedly in maximum security prisons. 
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During supplementation of PCF with ACF, 55 out of 297 (19%) smear positive TB cases 
in MASP were diagnosed through ACF while only 10 of 37 (27%) in MESP were from 
ACF. Overall 65 of 334 (19%) smear positive TB cases from both prisons types were 
diagnosed through ACF (Graph 4.1). 
 
 
Graph 4.0: TB cases diagnosed against suspects during ACF in prisons from 2009 to  
                    2010 
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Graph 4.1: Showing Percentage contribution of TB cases diagnosed through ACF as 
                   Supplement to PCF from 2009 to 2010 
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4.2: Trend of passive case notification rates of smear positive TB following  
        introduction of P-ACF  
 
After initiating ACF in the selected prisons, TB case notification rates during intervals of 
passive case finding (PCNR) were decreasing following each round of ACF in both 
maximum and medium security prisons. However, statistical significant decrease was 
noted after second round of ACF in both types of prisons (Table 4.0).  
 
Eight month after a third round of ACF, there was a statistical significant increase in 
passive case notification rate (PCNR) in both maximum and medium security prisons as 
compared to the period before the third round of ACF, but the PCNR of eight months 
after the third round of ACF was still significantly lower only in maximum security 
prisons than that of a similar duration, before the first round of ACF. (OR= 0.47; Chi-
squared= 21.936; p< 0.0005).
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TABLE 4.0: Trend of Passive case notification rates of smear positive TB on an 8 months interval after introduction of P-ACF  
 
                      in prisons from 2009 to 2010 
 
 
PERIOD OF 
PCF 
MAXIMUM SECURITY PRISON  
CHI-
SQUARED   
(p-value) 
MEDIUM SECURITY PRISON  
CHI-
SQUARED  
(p-value) 
TB 
CASES 
POPULATION 
AT RISK 
 
PCNR 
TB 
CASES 
POPULATION 
AT RISK 
 
PCNR 
 
Before first 
ACF 
 
115 
 
8498 
 
1353 
  
16 
 
1917 
 
835 
 
 
Before 
second ACF 
 
96 
 
9249 
 
1038 
      3.713 
(<0.10) 
 
   OR= 0.76 
 
10 
 
2190 
 
457 
        2.317 
(<0.20) 
    
   OR= 0.55 
 
Before third 
ACF 
 
31 
 
9352 
 
331 
     34.221 
(< 0.0005) 
OR= 0.32 
 
1 
 
2363 
 
42 
       8.098 
(<0.005) 
    OR= 0.09 
 
After third 
ACF 
 
55 
 
8574 
 
641 
       9.008 
(<0.005) 
   OR= 1.94 
 
20 
 
1949 
 
1026 
        21.341 
(<0.0005) 
    OR=24.49 
 
 
 
PCNR= Passive Case Notification Rate per 100,000 prisoners.      OR = Odds Ratio 
Significance tested at alpha < 0.05
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4.3 Trend of sum of active and passively diagnosed smear positive TB cases during 
every 8 monthly interval 
Following an eight monthly interval supplementation of PCF with ACF, there was an 
improvement in smear positive TB case notification at each interval due to additional 
cases diagnosed during ACF. However, an increase in the sum of actively and passively 
diagnosed cases was initially noted but was progressively reducing with each preceding 
eight months interval in both MASP and MESP (Graph 4.2). Interestingly, was an 
increase in smear positive TB cases diagnosed passively within eight months after a third 
round of ACF in both prison types than in the third interval which comprise of cases from 
a third ACF and PCF (After ACF 3 on the graph 4.2). 
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Graph 4.2: Trend of the sum of actively and passively diagnosed smear positive TB  
                    Cases from 2009 to 2010 
 
 
 
NOTE 
Each bar in this graph represents a sum of smear positive TB cases diagnosed during a 
round of ACF and in an 8 months PCF period before that round of ACF.  
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4.4 Additional costs to implement ACF in the study from 2009 to 2010 
The only additional costs in implementing active case finding were the direct non-
medical costs, which were on allowances for personnel and fuel, as additional personnel 
had to travel to other prisons to perform the screening since during this time, a lot of 
manpower is needed. 
 
All the other costs remained constant, as they would still have been incurred with 
passive case finding, since the study was happening in the same institutions. 
 
Allowances and fuel costs were accessed from vouchers in the accounts department of 
Malawi prison headquarters. Maximum-security prisons needed more personnel than the 
medium security hence more financial resources in allowances spent at maximum-
security prisons. 
 
Expenditure on allowances was the same in each maximum-security prison as the same 
number of personnel and days were allocated in these prisons. The same applied to 
medium security prisons. The only difference among same category of prisons was on 
fuel costs due to different distances as all personnel had to operate from Zomba or 
Lilongwe (Figure 1). Those from Zomba, were travelling to Chichiri, Chikwawa, Ntcheu 
and Lilongwe (Maula), while those from Maula were travelling to assist with screening at 
Mzimba prison.  
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The total additional cost of conducting 3 rounds of ACF in all 3 maximum-security 
prisons was MKW935, 370 while for all medium security prisons was MKW 552,360 
(Table 4.1). All the costs were in local currency, Malawi Kwacha (MKW)(1 US dollar = 
151 MKW). 
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TABLE 4.1: SHOWING ADDITIONAL COSTS SPENT (IN MWK) SPENT IN CONDUCTING ACF IN PRISON FROM  
FROM 2009 TO 2010 
 
PRISON TYPE PRISON NAME ALLOWANCES 
PER ROUND 
OF ACF 
FUEL PER 
ROUND OF 
ACF 
TOTAL COST 
PER ROUND 
OF ACF 
TOTAL COST 
FOR 3 ROUND 
OF ACF 
TOTAL 
 
Maximum 
 
Zomba 
 
92000 
 
4800 
 
96800 
 
290400 
 
 
 
 
935370 
 
Chichiri 
 
92000 
 
7600 
 
99600 
 
298800 
 
Maula 
 
92000 
 
23390 
 
115390 
 
346170 
 
Medium 
 
Chikwawa 
 
50000 
 
5850 
 
55850 
 
167550 
 
 
 
 
552360 
 
Ntcheu 
 
50000 
 
8780 
 
58780 
 
176340 
 
Mzimba 
 
50000 
 
19490 
 
69490 
 
208470 
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4.5 Additional smear positive TB cases diagnosed for the added costs during   
      periodic active case finding 
 
Clear differences of additional smear positive TB cases diagnosed for added costs 
following three rounds of ACF were seen in maximum and medium security prisons. 
Overall, 6 smear positive TB cases were diagnosed in maximum prisons for every added 
MKW 100000 spent as opposed to 2 in the medium security prisons. 
A varying trend was observed in each round of active case finding in both maximum and 
medium security prisons (Graph 4.3). The number of cases diagnosed per every MKW 
100000 added, was progressively reducing in each subsequent round of ACF in the order 
of 9, 6 and 3 for maximum security prisons while for medium security prisons was 3, 2 
and 0. Tuberculosis cases diagnosed per MKW 100000 spent in the first round in MESP 
are the same like that of the third round in the MASP. The average TB cases diagnosed 
per MKW 100000 spent in MASP are the same as that from the second ACF round in the 
same MASP. One striking thing was that in the first two rounds of ACF, three times 
smear positive cases in medium security prisons per MKW 100000 added were diagnosed 
in maximum-security prisons and also a third round of ACF in medium prisons yielded 
no case (Graph 4.3). 
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Graph 4.3: Additional TB Cases diagnosed per every added MKW 100000 spent in       
each round of ACF in prison from 2009 to 2010                                                                     
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5.0 DISCUSSION 
 
5.1 Contribution of ACF towards total smear positive TB cases diagnosed as  
      supplementation of PCF 
 
Three round of ACF of smear positive TB using microscopy in prisons done at intervals 
of 8 months apart, yielded additional 55 and 10 smear positive TB cases in maximum and 
medium security prisons respectively which represents an average of 19% of total case 
load within study prisons and period. This phenomenon has also been seen before in slum 
communities in Uganda (Sekandi et al., 2009), Ethiopia (Yimer et al., 2009), India 
(Santha et al., 2003) and also from Zomba prison in Malawi (Nyangulu et al, 1997), 
where undiagnosed smear positive TB cases were detected among chronic coughers.  
 
Malawi prisons being among the highly congested community where the infrastructure is 
so poor coupled with very poor ventilation and other risk factors that lead to TB infection 
and propagation (Table1.2), prevalence rates of TB are expected to be higher than in the 
general population. Higher prevalence rates of smear positive TB in Malawi have been 
reported in Chichiri, Maula and Zomba (maximum security) prisons at 1.1% (Banda et 
al., 2009) than in small prison (0.3%) which here are referred to as medium security 
prisons.  
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HIV/AIDS, leads to fast progression of TB infection to active disease. Recent prevalence 
survey for HIV in prisons has shown higher rates of HIV in maximum-security prisons of 
Chichiri, Maula and Zomba at 40.6% (Malawi Prisons Service, 2011) than in medium 
security prisons at 22.9%. Apart from differences in TB and HIV prevalence rates 
between the two kinds of prisons, maximum-security prisons (MASP) accommodate 
larger population of prisoners (Table 2.0) than medium security prisons (MESP), so it is 
not surprising to diagnose a more additional cases in maximum-security prisons than in 
medium security prisons. This has been already witnessed in the prison tuberculosis 
caseload the years before ACF was introduced (Table 1.3). However, no statistical 
significant differences were noted in the number of TB suspects whose sputum was 
examined to get 1 case of smear positive TB (48 in MASP and 60 in MESP). 
 
Most of the factors such as structure and congestion, which influence the spread, and 
propagation of TB disease in Malawi prisons need enough time to be dealt with and 
involve several stakeholders. In this situation, prisons will still be affected by high 
prevalence rates of smear positive TB, hence there would still be need to periodically 
conduct active screening of prisoners apart from the routine passive case finding in 
prisons. 
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The trend observed in graph 4.2, is similar to the one modelled by Dodd et al. (2011), 
who hypothesized that alternating ACF with PCF could result in diagnosis of increased or 
decreased cumulative TB cases. However, Dodd et al. (2011), further hypothesized that 
there is a tendency of an increased cumulative sum of cases following supplementation of 
PCF with active case finding in the initial rounds, which later progressively reduces with 
the subsequent rounds of ACF. The evidence from the study shown in Graph 4.2 shows 
the peak of cumulative sum of smear positive TB cases from PCF and ACF after the first 
round of ACF in both prison types. 
 
 
5.2 Reduction in passive case notification rates of smear positive TB following 
      introduction of P-ACF 
A progressive decrease in passive case notification rate in between rounds of ACF was 
noted, though this decrease was only significant after second round of ACF in both prison 
types. Since transmission of TB was noted to be taking place in prisons (Stead, 1978; 
Nyangulu et al., 1997) and Styblo hypothesized that one prevalent case of smear positive 
TB could lead to between 8 and12 tuberculosis new infections (Van Leth, van der Werf 
& Borgdorff, 2009), though it has shown that these infections might be fewer in 
developed countries, early diagnosis through ACF would prevent transmission to other 
prisoners as it shortens duration of infectiousness (Verver, 2001; Sekandi, 2009; Yimer, 
2009). This will finally result in progressive reduction in incident cases during PCF 
period hence resulting into reduction in passive case notification rates of smear positive 
TB as depicted in Table 4.0 
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The initial cumulative smear positive TB cases diagnosed by both rounds of ACF and 
through routine services (PCF) were higher due to diagnosis of a backlog of cases 
diagnosed from ACF. As most cases are believed to be from recent transmission due to 
fast progression following high HIV prevalence in prisons than the general community, it 
was not surprising that after the first round of ACF, the incident cases might have 
reduced due to prevention of transmission as Dodd et al. (2011), suggested that there 
would be reductions in cumulative HIV co-infected smear positive cases following ACF 
where more than 40% of incident TB cases are attributed to recent infection. This 
reduction in incidence cases was also observed in prisons of Russia (Lobacheva et al., 
2005) and Spain (Rodrigo et al, 2002) following periodic and entry screening. This 
reduction in passive case notification rates, may also indirectly show that the prevalence 
rates at that time, might have reduced as well as they are interrelated, a thing that was 
also found in Zimbabwe after conducting a series of active case finding in a community 
(Corbett et al., 2010). 
 
Following three rounds of ACF, passive case notification rates of smear positive TB 
remained statistically lower than that of the first 8 months before the first round of ACF 
in MASP only, unlike in the MESP where the only reduction was after the second round 
of ACF. This may be attributed to removal of a backlog of cases, hence interruption of   
transmission among contacts of smear positive TB in MASP. It is expected that there 
would be high transmission among prisoners in MASP as they do not go out of the fence 
to do some work as is the case in MESP. In this situation, removal of a backlog of cases 
would quickly reduce the incidence hence a sustained reduction in PCNR.  
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The rise in PCNR coming up after a third round of ACF might be due to diagnosis of 
cases that are HIV negative that were infected earlier before the start of ACF, since it has 
been seen that many prisoners develop TB on an average of 19 months in Tanzania 
(Rutta et al., 2000) and 12 to 18 months in Russia (Lobacheva et al., 2005) after entry to 
prison or after being infected. 
 
 
5.3 Variations in additional costs for conducting ACF in prisons 
Cumulatively, almost two times costs as in MESP were incurred in MASP due to more 
personnel allowances in MASP. This was so, as more personnel were needed in MASP 
due to larger population being accommodated and screened in MASP. The variations in 
costs in similar types of prisons are brought up due to different distances to be travelled 
by personnel conducting ACF, hence different costs in fuel (Table 4.1). 
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5.4 Additional TB cases per extra MKW 100,000 spent on ACF 
During active case finding, more cases per every MKW 100,000 added were diagnosed in 
MASP through out all the 3 rounds than in MESP. An average of 6 smear positive TB 
cases were diagnosed in the MASP as opposed to 2 in MESP. The three times number of 
cases per MKW 100,000 as in MESP diagnosed in MASP can be attributed to the high 
prevalence of smear positive TB in MASP as reported by Banda et al. (2007), a thing 
which is also manifesting in this study as it has been seen from higher rates of passive 
case notification of TB in MASP (Table 4.0), since case notification rates are 
proportional to the prevalence rates. This observation is in line with recommendations by 
Golub et al. (2005), who suggested that ACF need to be considered where the prevalence 
of TB is high, as the resources incurred in ACF would correspond well with the yield. 
The worst existing conditions such as overcrowding, poor ventilation and high 
HIV/AIDS in MASP than in MESP contributes to higher prevalence rates of TB in 
MASP than in MESP  
 
After carefully assessing additional costs for conducting ACF in MESP, it may be 
observed that the basic amount incurred might be too high for the ACF to match the yield 
per MKW100, 000 spent in MASP. However, this may be inevitable due to the minimum 
number of staff categories required to conduct ACF. The observations from this variable, 
shows that there is no relevance in continuing with ACF after doing a second round of 
ACF in MASP, and also that ACF would be more effective in MASP. 
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5.5 Interpretation of research results from the hypothesis testing 
 
The study results show the evidence of rejecting the null hypothesis (H0) with less than 
0.05% probability of making an error. However, this is only evident in maximum-
security prisons while in medium security prisons, the null hypothesis would be accepted. 
Therefore, the extra costs of implementing three rounds of active case finding in prisons 
justify the added utility of the program by reducing the passive case notification rates of 
smear positive TB only in maximum security prisons of Malawi. 
 
5.6 Research Results Generalization 
The research results from this study would only be generalized to prisons of similar 
nature and conditions in Africa where prevalence of HIV and smear positive TB are the 
same or similar to that of Malawi. This would be reliably seen in sub-Saharan Africa 
countries where conditions of imprisonment are as in Malawi. 
 
5.7 Research results dissemination 
The researcher intends to disseminate the results of the study first to management of 
Malawi prisons when it is passed thereafter to national conference like the Malawi 
College of Medicine research dissemination conference of 2013. There are also plans to 
have the findings published in a reputable journal. The whole findings can influence on 
the policy of TB in prisons. 
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6. CONCLUSION AND RECOMMENDATIONS 
The study has shown that implementation of periodic active case finding sustainably 
reduced the passive case notification rate of smear positive tuberculosis in maximum-
security prisons from 2009 to 2010. 
 
Despite a minimal increase in PCNR after the third round of ACF, PCNR still remained 
statistically significant lower at p-value 0.05 (alpha 5%) than the one of similar duration 
of 8 months before the first round of ACF. 
 
On the other note, it was found that during each round of ACF, three times smear positive 
TB cases diagnosed in MESP were detected in MASP, which shows that conducting ACF 
in MASP was more cost effective than in MESP as the whole aim of conducting ACF 
was to diagnosed more cases earlier so that they be initiated on treatment to stop further 
spread. This being the case, it would be more efficient to limit periodic active case 
finding to maximum security prisons only as it is where more cases are diagnosed and 
there is also significant reduction in case notification rates of TB.  
 
Having seen that the number of smear positive TB cases diagnosed per additional 
MKW100, 000 spent on ACF were reducing with each subsequent round of ACF 
conducted and that the average number (6 cases per MKW100, 000) in MASP was the 
same as that of the second round of ACF in the same prison types, the study would 
recommend a repeat of the same study at a later time to ascertain whether the average 
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number of cases would still be the same as in the second round, so that a decision to 
conduct only two rounds of ACF would be enough , and there after a strengthen passive 
case finding and contact tracing would take over to continuously reduce or maintain low 
rates of smear positive TB. 
 
The challenge encountered in the study was the diagnosing method for TB used during 
screening. As rates for HIV are so high in Malawi prisons, it was more likely that some 
cases would not be detected, as the smear positivity is often very low in HIV positive 
people. 
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Appendix 2 
 
LIST OF PRISON STATIONS IN MALAWI 
 
EASTERN 
REGION 
SOUTHERN 
REGION 
CENTRAL 
REGION 
NORTHERN 
REGION 
1. Domasi 
2. Mangochi 
3. Mikuyu 1 
4. Mikuyu 2 
5. Ntcheu 
6. Mpyupyu 
7. Zomba central 
  8. Chichiri 
  9. Bvumbwe 
10. Chikwawa 
11. Makande 
12. Mulanje 
13. Mwanza 
14. Nsanje 
15. Thyolo 
16. Makhanga 
17. Luwani 
18. Bangula 
19. Byanzi 
20. Dedza 
21. Kachere 
22. Kasungu 
23. Maula 
24. Ntchisi 
25. Nkhotakota 
26. Chitipa 
27. Karonga 
28. Mzimba 
29. Mzuzu 
30. Nkhatabay 
31. Rumphi 
32. Old Mzimba  
 
 
 
 
 
Appendix 3: Formula for calculating PCNR 
 
Case Notification rate for Smear positive TB  
 = (Number of smear positive TB cases diagnosed over the period divide by the 
population at risk over same period of time) multiply by 100000. 
